Dr. Saeed Mohammad, MD
Pediatric Gastroenterology (Pediatric Transplant Hepatology Physician)
At a glance
- In the NPI registry since
- 2007
Licensed in Illinois since 2008, according to the Illinois Department of Financial and Professional Regulation. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pediatric Transplant Hepatology Physician primary
TN license 43689 -
Pediatric Gastroenterology Physician
IL license 036-121789 (first issued 2008; not renewed) · MI license 4301106779 · TN license 43689 -
Pediatrics Physician
IL license 036-121789 (first issued 2008; not renewed) · TN license 43689
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Payments from drug and device companies
In 2025, 3 companies reported 36 payments worth $54,008 in total to this clinician.
| Ipsen Biopharmaceuticals, Inc | $41,858 |
|---|---|
| Mirum Pharmaceuticals, Inc. | $11,990 |
| Bracco Diagnostics Inc. | $159 |
| Compensation for services other than consulting (speaking, faculty) | $36,032 |
|---|---|
| Consulting Fee | $14,109 |
| Travel and Lodging | $2,802 |
| Food and Beverage | $1,066 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc Jan 1, 2025 | Compensation for services other than consulting (speaking, faculty) Bylvay · Gastroenterology | $12,623 |
| Ipsen Biopharmaceuticals, Inc Jul 23, 2025 | Compensation for services other than consulting (speaking, faculty) Bylvay · Gastroenterology | $5,967 |
| Ipsen Biopharmaceuticals, Inc Dec 9, 2025 | Compensation for services other than consulting (speaking, faculty) Bylvay · Gastroenterology | $5,967 |
| Ipsen Biopharmaceuticals, Inc Mar 24, 2025 | Compensation for services other than consulting (speaking, faculty) Bylvay · Gastroenterology | $4,590 |
| Mirum Pharmaceuticals, Inc. Nov 18, 2025 | Consulting Fee Livmarli · Alagille syndrome | $3,080 |
| Ipsen Biopharmaceuticals, Inc Jan 17, 2025 | Consulting Fee Bylvay · Gastroenterology | $2,944 |
| Ipsen Biopharmaceuticals, Inc Jun 11, 2025 | Compensation for services other than consulting (speaking, faculty) Bylvay · Gastroenterology | $2,754 |
| Mirum Pharmaceuticals, Inc. Nov 18, 2025 | Consulting Fee Livmarli · Alagille syndrome | $2,695 |
| Mirum Pharmaceuticals, Inc. Feb 1, 2025 | Consulting Fee | $1,540 |
| Mirum Pharmaceuticals, Inc. Mar 12, 2025 | Consulting Fee Livmarli · Alagille syndrome | $1,540 |
All 26 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc Dec 9, 2025 | Compensation for services other than consulting (speaking, faculty) Bylvay · Gastroenterology | $5,967 |
| Ipsen Biopharmaceuticals, Inc Dec 9, 2025 | Travel and Lodging Bylvay · Gastroenterology · travel to St. Louis, MO · in-kind | $546 |
| Ipsen Biopharmaceuticals, Inc Dec 9, 2025 | Travel and Lodging Bylvay · Gastroenterology · travel to St. Louis, MO · in-kind | $232 |
| Mirum Pharmaceuticals, Inc. Nov 18, 2025 | Consulting Fee Livmarli · Alagille syndrome | $3,080 |
| Mirum Pharmaceuticals, Inc. Nov 18, 2025 | Consulting Fee Livmarli · Alagille syndrome | $2,695 |
| Mirum Pharmaceuticals, Inc. Nov 18, 2025 | Travel and Lodging Livmarli · Alagille syndrome · travel to Germantown, TN | $297 |
| Mirum Pharmaceuticals, Inc. Nov 18, 2025 | Travel and Lodging Livmarli · Alagille syndrome · travel to Germantown, TN | $232 |
| Mirum Pharmaceuticals, Inc. Nov 18, 2025 | Travel and Lodging Livmarli · Alagille syndrome · travel to Germantown, TN | $10.50 |
| Ipsen Biopharmaceuticals, Inc Sep 18, 2025 | Compensation for services other than consulting (speaking, faculty) Bylvay · Gastroenterology | $1,377 |
| Ipsen Biopharmaceuticals, Inc Aug 11, 2025 | Compensation for services other than consulting (speaking, faculty) Bylvay · Gastroenterology | $1,377 |
| Ipsen Biopharmaceuticals, Inc Jul 23, 2025 | Compensation for services other than consulting (speaking, faculty) Bylvay · Gastroenterology | $5,967 |
| Ipsen Biopharmaceuticals, Inc Jul 23, 2025 | Travel and Lodging Bylvay · Gastroenterology · travel to Park Ridge, IL · in-kind | $540 |
| Ipsen Biopharmaceuticals, Inc Jul 23, 2025 | Travel and Lodging Bylvay · Gastroenterology · travel to Park Ridge, IL · in-kind | $313 |
| Ipsen Biopharmaceuticals, Inc Jun 25, 2025 | Travel and Lodging Bylvay · Gastroenterology · travel to Aurora, CO · in-kind | $294 |
| Ipsen Biopharmaceuticals, Inc Jun 25, 2025 | Travel and Lodging Bylvay · Gastroenterology · travel to Aurora, CO · in-kind | $37.65 |
| Ipsen Biopharmaceuticals, Inc Jun 11, 2025 | Compensation for services other than consulting (speaking, faculty) Bylvay · Gastroenterology | $2,754 |
| Ipsen Biopharmaceuticals, Inc Apr 29, 2025 | Compensation for services other than consulting (speaking, faculty) Bylvay · Gastroenterology | $1,377 |
| Ipsen Biopharmaceuticals, Inc Mar 24, 2025 | Compensation for services other than consulting (speaking, faculty) Bylvay · Gastroenterology | $4,590 |
| Mirum Pharmaceuticals, Inc. Mar 12, 2025 | Consulting Fee Livmarli · Alagille syndrome | $1,540 |
| Mirum Pharmaceuticals, Inc. Mar 7, 2025 | Consulting Fee Livmarli · Alagille syndrome | $770 |
| Mirum Pharmaceuticals, Inc. Mar 4, 2025 | Consulting Fee | $770 |
| Mirum Pharmaceuticals, Inc. Feb 12, 2025 | Consulting Fee Livmarli · Alagille syndrome | $770 |
| Mirum Pharmaceuticals, Inc. Feb 1, 2025 | Consulting Fee | $1,540 |
| Ipsen Biopharmaceuticals, Inc Jan 17, 2025 | Consulting Fee Bylvay · Gastroenterology | $2,944 |
| Ipsen Biopharmaceuticals, Inc Jan 1, 2025 | Compensation for services other than consulting (speaking, faculty) Bylvay · Gastroenterology | $12,623 |
| Ipsen Biopharmaceuticals, Inc Jan 1, 2025 | Travel and Lodging Bylvay · Gastroenterology · travel to Dallas, TX · in-kind | $299 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 3 companies. The companies reported $120,471 in research payments for these studies, mostly to the institutions running them.
- A Prospective, Observational, Non-Interventional, Post-Marketing, Patient Registry to Collect Data on Routine Clinical Care in Patients Treated With Cholbam (Cholic Acid) (REPLACE)
Mirum Pharmaceuticals, Inc. - Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome
Albireo Pharma, Inc. · Active, not recruiting · NCT05035030 - A Phase 2/3 Randomized, Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Alafenamide in Children Adolescents with Chronic Hepatitis B Infection
Gilead Sciences, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.